Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

861
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
861
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

988
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
988
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

729
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
729

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual Meeting.

The Journal of rheumatology·2026
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials.

Rheumatology and therapy·2026
Same author

Immune Checkpoint Inhibitor-Associated Uveitis Treated with the 0.19 Mg Fluocinolone Acetonide Intravitreal Implant: Clinical Outcomes in a Retrospective Case-Series.

Ocular immunology and inflammation·2026
Same author

GRAPPA Research Projects: Development of Criteria for Axial Psoriatic Arthritis and Definitions of Complex-to-Manage and Treatment-Refractory Psoriatic Arthritis.

The Journal of rheumatology·2026

Related Experiment Video

Updated: Dec 8, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.7K

Uveitis in spondyloarthritis.

Judith Rademacher1, Denis Poddubnyy2, Uwe Pleyer3

  • 1Department of Gastroenterology, Infectiology and Rheumatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 30, Berlin, 10117, Germany.

Therapeutic Advances in Musculoskeletal Disease
|September 23, 2020
PubMed
Summary
This summary is machine-generated.

Uveitis, an eye inflammation, frequently affects axial spondyloarthritis (SpA) patients. Early diagnosis and collaboration between eye and rheumatology specialists are crucial for managing SpA and preventing vision loss.

Keywords:
spondyloarthritisuveitis

More Related Videos

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.7K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.0K

Related Experiment Videos

Last Updated: Dec 8, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.7K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.7K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.0K

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Uveitis is the most common extra-articular manifestation of axial spondyloarthritis (SpA), affecting up to one-third of patients.
  • Acute anterior uveitis (AAU) presents with photosensitivity, pain, and blurred vision, often requiring systemic treatment for refractory cases.
  • The pathogenesis involves genetic predisposition (e.g., HLA-B27), environmental factors, and immune system activation.

Purpose of the Study:

  • To highlight the significant association between uveitis and axial spondyloarthritis.
  • To emphasize the need for improved diagnostic strategies for SpA in AAU patients.
  • To underscore the importance of multidisciplinary collaboration for optimal patient management.

Main Methods:

  • Review of current literature on uveitis in axial spondyloarthritis.
  • Analysis of the clinical presentation and treatment strategies for uveitis in SpA.
  • Discussion of the diagnostic challenges and referral pathways for SpA in AAU patients.

Main Results:

  • Up to 40% of AAU patients may have undiagnosed SpA, necessitating prompt rheumatological referral.
  • Ophthalmological manifestation risk increases with SpA disease duration.
  • Effective management requires a coordinated approach involving patients, rheumatologists, and ophthalmologists.

Conclusions:

  • Prompt referral and diagnosis of SpA in AAU patients are essential to prevent long-term complications.
  • Integrated care models are vital for managing the ocular and systemic aspects of SpA-associated uveitis.
  • Further research into SpA pathogenesis may reveal novel therapeutic targets for uveitis.